Use of Anti-TNF a Agents (Infliximab and Etanercept) in Rheumatoid Arthritis and Ankylosing Spondylitis: Experience of a Rheumatology Practice at Apollo Hospitals, India

Autor: Upadhyaya, Sundeep K.
Zdroj: Apollo Medicine; June 2005, Vol. 2 Issue: 2 p147-149, 3p
Abstrakt: A retrospective analysis of the use of Biological Response Modifiers (BRMs) infliximab and etanercept in patients with inflammatory spine (ankylosing spondylitis-AS) and inflammatory joint conditions (rheumatoid arthritis-RA) – experience of the author at Apollo Hospitals, Hyderabad and Indraprastha Apollo Hospitals, New Delhi over the past 5 years.
Databáze: Supplemental Index